9999999997-17-005256.txt : 20170403 9999999997-17-005256.hdr.sgml : 20170403 20170403100554 ACCESSION NUMBER: 9999999997-17-005256 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170403 DATE AS OF CHANGE: 20170403 20170403 20170403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 17732635 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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